MIB-1 monoclonal antibody to determine proliferative activity of Ki-67 antigen as an adjunct to the histopathologic differential diagnosis of Spitz nevi

Journal of the American Academy of Dermatology

Volumn 44, Issue 3, 2001, Pages 500-504

  Bergman, Reuven ^a,c   Malkin, Leonid ^a   Sabo, Edmond ^b   Kerner, Hedviga ^a,c  

^a RAMBAM MEDICAL CENTER   (Israel)

^b BNAI ZION MEDICAL CENTER   (Israel)

^c TECHNION ISRAEL INSTITUTE OF TECHNOLOGY   (Israel)

Author keywords

[No Author keywords available]

Indexed keywords

KI 67 ANTIGEN; MONOCLONAL ANTIBODY KI 67;

ANTIBODY LABELING; ARTICLE; CANCER DIAGNOSIS; CELL COUNT; CELL PROLIFERATION; CLINICAL ARTICLE; DIFFERENTIAL DIAGNOSIS; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; JUVENILE MELANOMA; MELANOCYTIC NEVUS; MELANOMA; PRIORITY JOURNAL; TUMOR CELL;

EID: 0035105879     PISSN: 01909622     EISSN: None     Source Type: Journal    
DOI: 10.1067/mjd.2001.111635     Document Type: Article

References (21)

1. Proliferative activity of cutaneous melanocytic tumors defined by Ki-67 monoclonal antibody: A quantitative immunohistochemical study
2. Prognostic significance of nuclear DNA content and proliferative activity in renal cell carcinomas: A clinicopathologic study of 58 patients using mitotic count, MIB-1 staining, and DNA cytophotometry
3. Prognostic significance of Ki-67 labeling indices obtained using MIB-1 monoclonal antibody in patients with supratentorial astrocytomas
4. Production of a mouse monoclonal antibody reactive with a human nuclear antigen associated with cell proliferation
5. New Ki-67-equivalent murine monoclonal antibodies (MIB 1-3) generated against bacterially expressed parts of the Ki-67 cDNA containing three 62 base pair repetitive elements encoding for the Ki-67 epitope
6. MIB-1 proliferative activity in primary and metastatic melanomas
7. Ki-67 immunostaining in melanocytic skin tumors: Correlation with histologic parameters
8. Immunohistochemical expression of BCL-2 in melanomas and intradermal nevi
9. Utility of a proliferation marker in distinguishing between benign naevocellular naevi and naevocellular naevus-like lesions with malignant properties
10. Proliferation marker Ki-S5 as a diagnostic tool in melanocytic lesions
11. Prognostic significance of MIB-1 proliferative activity in thin melanomas and immunohistochemical analysis of MIB-1 proliferative activity in melanocytic tumors
12. Immunohistochemical markers for distinguishing Spitz nevi from malignant melanomas
13. Cyclin D1 overexpression in Spitz nevi: An immunohistochemical study
14. Nevus cell maturation or atrophy?
15. The pattern of HMB-45 antibody staining in compound Spitz nevi
16. MIB-1 immunoreactivity correlates with metastatic dissemination in primary thick cutaneous melanoma
17. Proliferative activities in Spitz nevus compared with melanocytic nevus and malignant melanoma using expression of PCNA/cyclin and mitotic rate
18. Immunohistochemical study of Spitz nevi and malignant melanoma with use of antibody to proliferating cell nuclear antigen
19. Proliferative activity in Spitz's naevi compared with other melanocytic skin lesions
20. Expression of proliferating cell nuclear antigen in Spitz nevus